TFIGlobal
TFIGlobal
TFIPOST English
TFIPOST हिन्दी
No Result
View All Result
  • Indo-Pacific
  • Americas
  • Canada
  • Indian Subcontinent
  • West Asia
  • Europe
  • Africa
  • The Caribbean
TFIGlobal
  • Indo-Pacific
  • Americas
  • Canada
  • Indian Subcontinent
  • West Asia
  • Europe
  • Africa
  • The Caribbean
No Result
View All Result
TFIGlobal
TFIGlobal
No Result
View All Result
  • Indo-Pacific
  • Americas
  • Canada
  • Indian Subcontinent
  • West Asia
  • Europe
  • Africa
  • The Caribbean

Malaysia snubs China despite Xi Jinping’s vaccine push, turns towards the USA

Sohil Sinha by Sohil Sinha
November 28, 2020
in Indo-Pacific
China, Malaysia, Vaccine, Pfizer
Share on FacebookShare on X

Malaysia has signed a deal with the United States pharmaceutical firm Pfizer for 12.8 million doses of coronavirus vaccines to treat 20% of its population. While the deal is essential for Malaysia to help it in vaccinating its citizens, it should come as no surprise that it also showcases the public failure of Xi Jinping’s diplomatic push to promote the China-made vaccine.

 

Also Read

Agroterrorism in U.S.? Chinese Scientists Accused of Smuggling Deadly Crop Fungus

RIC Revival: Russia looks to bring in China and India to resurrect the RIC trio

U.S. Warns of Growing Global Dangers in 2025 Threat Report

The accord for 12.8 million doses to inoculate 6.4 million people is contingent on Pfizer’s vaccine being approved by the U.S. Food and Drug Administration and Malaysia’s drug regulator, Prime Minister Muhyiddin Yassin revealed in a televised conference on Friday. The doses will cover around 6.4 million people in the Southeast Asian country.

 

On Twitter, The Malaysian Minister of Science Technology and Innovation Khairy Jamaluddin described the Pfizer agreement as the country’s ‘first COVID-19 deal’.

 

PM ⁦@MuhyiddinYassin⁩ has just announced our first COVID-19 vaccine deal.

Gov't inks deal with Pfizer to vaccinate 6.4 million Malaysians https://t.co/2ZdN1yO89c

— Khairy Jamaluddin 🇲🇾🌺 (@Khairykj) November 27, 2020

 

As for the Chinese agreement, he said “work is being done on the commercial terms and clinical data evaluation with individual manufacturers.”

 

China had offered priority access to Malaysia for its coronavirus vaccines, in a Facebook post, Muhyiddin said the outgoing Chinese envoy Bai Tian had offered that assurance in a farewell meeting, when he also conveyed Beijing’s “appreciation of the government of Malaysia for giving continuous support in various aspects to the republic, especially when the COVID-19 pandemic hit Wuhan early this year”.

 

China signed a deal with Malaysia in early November this year, to cooperate on the development COVID-19 vaccine. Under the pact, Malaysia will be given priority access to vaccines developed by China during a five-year period. The countries also agreed to share knowledge and expertise on matters related to the development on the vaccine.

 

But with China losing pace to the US, UK, Russian, and Indian developed vaccines, Malaysia

found it apt to sign a deal with the US Pfizer vaccine. 

Read More: India’s Energy and Vaccine diplomacy – A masterplan to snatch Myanmar, Sri Lanka, Maldives, and Bangladesh from China

The decision to sign for a US-based vaccine company in China’s backyard shows the level of distrust that has seeped into Chinese relations since the Pandemic originated in Wuhan. With the ties already failing with the West, the Malaysian deal speaks volumes.

 

Despite China’s persistent and detailed outreach, Malaysia has chosen to go with the US manufactured Pfizer as the first line of defense against the virus. Moreover, it also indicates that the States in the international order – big or small, are now reluctant to engage with China on issues critical to their national security and survival.

 

The United States’ trade war with China in the wake of the pandemic opened up a clear divide in the Indo-Pacific and with Malaysia’s latest actions, the United States holds the clear advantage. It also serves as a message to China that Malaysia refuses to partake in China’s growing belligerence in the region or enable China’s rise.

Tags: ChinaMalaysiaPfizerShort takesVaccine
ShareTweetSend
Sohil Sinha

Sohil Sinha

Also Read

US Defense Secretary Urges Asian Allies: Boost Defence Spending

US Warns China at Shangri-La Dialogue: “We’re Ready to Fight and Win”

May 31, 2025
Trump mulls troop withdrawal from South Korea, Indo Pacific up for grabs?

Trump mulls troop withdrawal from South Korea, Indo Pacific up for grabs?

May 23, 2025
Turmoil in Philippines continues as the Duterte and Marcos families battle it out in the elections

Turmoil in Philippines continues as the Duterte and Marcos families battle it out in the elections

May 15, 2025
North Korea successfully test-fires surface-to-air missile

North Korea successfully test-fires surface-to-air missile, as South Korea and the United States conduct joint military drills

March 22, 2025
A New Alliance in Making, Philippines invites India to Join 'Squad'

Philippines invites India and South Korea to Join ‘Squad’ to deter Chinese Influence in its region

March 21, 2025
China Response to US Accusations on Fentanyl Trade

“US should say thank you”: China Rejects US Accusations on Fentanyl Trade

March 13, 2025
Youtube Twitter Facebook
TFIGlobalTFIGlobal
Right Arm. Round the World. FAST.
  • About Us
  • Contact Us
  • TFIPOST – English
  • TFIPOST हिन्दी
  • Careers
  • Brand Partnerships
  • Terms of use
  • Privacy Policy

©2025 - TFI MEDIA PRIVATE LIMITED

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Indo-Pacific
  • Americas
  • Canada
  • Indian Subcontinent
  • West Asia
  • Europe
  • Africa
  • The Caribbean
TFIPOST English
TFIPOST हिन्दी

©2025 - TFI MEDIA PRIVATE LIMITED

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. View our Privacy and Cookie Policy.